Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Dow
McKinsey
Medtronic
Johnson and Johnson
McKesson
Moodys

Last Updated: November 20, 2019

DrugPatentWatch Database Preview

QUARTETTE Drug Profile

See Plans and Pricing

« Back to Dashboard

When do Quartette patents expire, and when can generic versions of Quartette launch?

Quartette is a drug marketed by Teva Branded Pharm and is included in one NDA. There are two patents protecting this drug and one Paragraph IV challenge.

This drug has twenty-four patent family members in thirteen countries.

The generic ingredient in QUARTETTE is ethinyl estradiol; levonorgestrel. There are twenty-six drug master file entries for this compound. Twenty-three suppliers are listed for this compound. Additional details are available on the ethinyl estradiol; levonorgestrel profile page.

Drug patent expirations by year for QUARTETTE
Drug Prices for QUARTETTE

See drug prices for QUARTETTE

Drug Sales Revenue Trends for QUARTETTE

See drug sales revenues for QUARTETTE

Recent Litigation for QUARTETTE

Identify potential future generic entrants

District Court Litigation
Case NameDate
Teva Women's Health, Inc. v. Famy Care Ltd.2014-12-05
Teva Women's Health, Inc. v. Famy Care Ltd.2014-07-02

See all QUARTETTE litigation

Synonyms for QUARTETTE
110541-57-6
18,19-Dinorpregn-4-en-20-yn-3-one, 13-ethyl-17-hydroxy-, (17-alpha)-, mixt. with (17-alpha)-19-norpregna-1,3,5(10)-trien-20-yne-3,17-diol
18,19-Dinorpregn-4-en-20-yn-3-one, 13-ethyl-17-hydroxy-, (17-alpha)-(+-)-, mixt. with (17-alpha)-19-norpregna-1,3,5(10)-trien-20-yne-3,17-diol
18,19-Dinorpregn-4-en-20-yn-3-one, 13-ethyl-17-hydroxy-, (17-alpha)-(+-)-,mixt. with (17-alpha)-19-norpregna-1,3,5(10)-trien-20-yne-3,17-diol
37263-36-8
39366-37-5
52232-43-6
55927-62-3
70208-30-9
8056-51-7
8063-84-1
8064-50-4
AC1L2NM9
Adepal
AG 200-15
AG200-15
aless
Alesse 28
Altavera
Anna
Anteovin
aviane
AVIANE-21
Aviane-21Fe
AVIANE-28
Biphasil
Biphasil 21
Biphasil 28
C21H28O2.C20H24O2
CCRIS 7261
CRYSELLE
dl-Norgestrel mixed with ethinylestradiol
DTXSID90192569
Duoluton
Ediwal
Elifemme
ENPRESSE-21
ENPRESSE-28
Ethinyl estradiol mixed with norgestrel
Ethinyl estradiol mixture with levonorgestrel
Ethinyl estradiol mixture with norgestrel
ETHINYL ESTRADIOL-NORGESTREL COMBINATION
ethinyl estradiol, levonorgestrel drug combination
Ethinyl estradiol/levonorgestrel
Ethinylestradiol - levonorgestrel mixt
Ethinylestradiol - levonorgestrel mixt.
Ethinylestradiol mixed with dl-norgestrel
Ethinylestradiol mixture with Levonorgestrel
Ethinyloestradiol mixed with norgestrel
Eugynon
Eugynon 30
Femenal
Follimin
Follinett
Follinyl
Gravistat
Gynatrol
Introvale
Jolessa
LESSINA-21
LESSINA-28
LEVLITE
Levonest
Levonorgestrel - ethynylestradiol mixt
Levonorgestrel - ethynylestradiol mixt.
Levonorgestrel and Ethinyl Estradiol
Levonorgestrel and Ethinyl Estradiol tablets
Levonorgestrel-ethinyl estradiol mixt
Levonorgestrel-ethinyl estradiol mixt.
Levonorgestrel, ethinyl estradiol
Levonorgestrel/ethinyl estradiol
Levora
LEVORA 0.15/30-21
LEVORA 0.15/30-28
Lo-Femenal
LO/OVRAL-28
LOC 31
LOC 31A
Logynon
Loseasonique
Low-ogestrel
LOW-OGESTREL-21
LOW-OGESTREL-28
LS-62088
LS-62092
Lybrel
Marlissa
Microgynon
Microgynon 30
Microvlar 30
Minidril
Minigynon
Minisiston
Neogynon
Neovlar
Neovletta
NORDETTE-21
NORDETTE-28
Nordiol
Nordiol-28
Norgestrel and Ethinyl Estradiol
Norgestrel mixed with ethinyl estradiol
Norgestrel mixed with ethinyloestradiol
Norgestrel-ethinyl estradiol
Norgestrel-Ethinyl Estradiol Combination
Norgestrel-ethynylestradiol mixt
Norgestrel-ethynylestradiol mixt.
OGESTREL 0.5/50-21
OGESTREL 0.5/50-28
Orasecron
Ovidon
Ovral 21
Ovral 28
Ovral L
OVRAL-28
Ovran
Ovranett
PC 4 (contraceptive)
Pearl Oral Contraceptive
Portia
PORTIA-21
PORTIA-28
PREVEN EMERGENCY CONTRACEPTIVE KIT
Primovlar
Pro-Duosterone
Quasense
Rigevidon
SCHEMBL4451192
Schering PC 4
Sequilar
Sequilarum
Sequostat
SH 71121
SH D00264A
SHB 261AB
SHB 264AB
Sronyx
Stederil 30
Stediril
Stediril D
Tri-Regol
Trigynon
Trikvilar
Trinordiol
Triphasil-21
TRIPHASIL-28
Triquilar
Trisiston
Trisistone R
Trisistone-R
TRIVORA-21
TRIVORA-28
Twirla
Vienva
WL 33
WY-E 104
Paragraph IV (Patent) Challenges for QUARTETTE
Tradename Dosage Ingredient NDA Submissiondate
QUARTETTE TABLET;ORAL ethinyl estradiol; levonorgestrel 204061 2013-07-10

US Patents and Regulatory Information for QUARTETTE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Teva Branded Pharm QUARTETTE ethinyl estradiol; levonorgestrel TABLET;ORAL 204061-001 Mar 28, 2013 AB RX Yes Yes   Start Trial   Start Trial Y   Start Trial
Teva Branded Pharm QUARTETTE ethinyl estradiol; levonorgestrel TABLET;ORAL 204061-001 Mar 28, 2013 AB RX Yes Yes   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Supplementary Protection Certificates for QUARTETTE

Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
1453521 122015000093 Germany   Start Trial PRODUCT NAME: LEVONORGESTREL UND ETHINYLESTRADIOL; NAT. REGISTRATION NO/DATE: 87675.00.00 20150720; FIRST REGISTRATION: SLOWAKEI 17/0017/15-S 20150129
1214076 C01214076/01 Switzerland   Start Trial PRODUCT NAME: DROSPIRENONE + ETHINYLESTRADIOL; REGISTRATION NUMBER/DATE: SWISSMEDIC 57946 13.06.2008
1453521 CA 2016 00016 Denmark   Start Trial PRODUCT NAME: LEVONORGESTREL OG ETHINYLOESTRADIOL; NAT. REG. NO/DATE: 56336 20151105; FIRST REG. NO/DATE: SK 17/0017/15-S 20150211
1380301 2009C/007 Belgium   Start Trial PRODUCT NAME: DROSPIRENONE-ETHINYLESTRADIOL; AUTHORISATION NUMBER AND DATE: BE321386 20080811
0771217 CA 2006 00038 Denmark   Start Trial PRODUCT NAME: ETHINYLESTRADIOL (SOM BETA-CYCLODEXTRIN-CLATHRAT) OG DROSPIRENON; NAT. REG. NO/DATE: 38687 20060627; FIRST REG. NO/DATE: EU RVG 31781 20050804
0398460 C300221 Netherlands   Start Trial PRODUCT NAME: DROSPIRENON EN ETHINYLESTRADIOL; REGISTRATION NO/DATE: RVG 23827 20000307
1453521 93156 Luxembourg   Start Trial PRODUCT NAME: LEVONORGESTREL ET ETHINYLESTRADIOL; FIRST REGISTRATION DATE: 20150211
>Patent Number >Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
Moodys
Baxter
Express Scripts
McKesson
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.